Sisi Directs 'Griffol' to Start Establishing Plasma Derivatives Centers in Egypt

President Abdel-Fattah El-Sisi met today Tuesday with Raymond Griffols and Victor Griffols, Chairmen of the Board of Directors of the Spanish company "Griffols" to collect and manufacture plasma derivatives.

The meeting was attended by both of   Dr. Mustafa Madbouly, Prime Minister, Dr. Hala Zayed, Minister of Health and Population,   Dr. Mohamed Awad Tajuddin, Advisor to the President of the Republic for Affairs Health and Prevention, Maj. Gen.  Dr. Bahaa El Din Zidan, Chairman of the Board of Directors of the Egyptian Consolidated Procurement Authority, Dr. Tamer Assem, Deputy Minister of Health and Population for Medicines Affairs, Maj.  Gen. Mostafa Amin, Director-General of the National Service Projects Authority, and Maj.  Gen.  Dr. Mustafa Abu Hatab, Director of the Global Medical Center, and Maj.  Gen. Dr. Magdy Amin, Director of the Armed Forces Medical Services Department.

Bassam Rady, the spokesperson for the Presidency of the Republic, stated that the meeting dealt with reviewing the executive general plan of the national project for the manufacture and assembly of plasma derivatives in Egypt, which will be carried out in partnership with the Spanish company "Griffols" with long experience in this field at the global level.

Sisi directed 'Griffols' to accelerate the executive schedule of the project, which represents a huge addition to the series of national projects that take care of the health of citizens by localizing the technology for manufacturing and assembling plasma in Egypt.

Sisi also directed them to carry out the project according to the highest international standards, in addition to transferring the company's experience with regard to managing plasma centers, starting from the stage of their collection and even production, in a way that contributes to possessing the capacity in this vital area, which has a direct impact on the health and safety of citizens.

The president also directed them to immediately start establishing plasma derivatives collection centers in Egypt and setting up an effective and accurate mechanism to ensure the reliability of performance in cooperation with the Spanish company.

He stressed the high priority represented by this project at the state level.